High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic leukemia in adults: Results of two six-day regimens
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults
1968 • 559 citations
High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
1979 • 290 citations
HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA
1977 • 218 citations
Treatment of Acute Myelogenous Leukemia in Children and Adults
1980 • 218 citations
Central nervous system toxicity of high-dose systemic cytosine arabinoside
1981 • 204 citations
Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens
1979 • 153 citations
Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens
1979 • 115 citations
DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA
1969 • 113 citations
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia
1975 • 85 citations
Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response
1974 • 77 citations
Chemotherapy of Acute Leukemia
1974 • 67 citations
Prolonged infusion of arabinosyl cytosine in childhood leukemia
1970 • 65 citations
Progress in the Treatment of Adults With Acute Leukemia
1976 • 64 citations
Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia
1980 • 58 citations
Cytarabine for Acute Leukemia in Adults
1974 • 44 citations